Contribution of Ultrasonography in the Evaluation of Cervical Induction-delivery Time
NCT ID: NCT02570620
Last Updated: 2025-12-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
342 participants
INTERVENTIONAL
2010-09-30
2014-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Observational cohort of patients
Patients will benefit from an ultrasonography of the cervix through endovaginal before induction of prostaglandins
Ultrasonography of the cervix
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ultrasonography of the cervix
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Single pregnancy to term (\> 37 weeks) in cephalic presentation
* Bishop score on the day of inclusion equal to 4.5 or 6
* Medical indication in accordance with professional recommendations of the April 2008 HAS.
Exclusion Criteria
* Placenta previa
* Parity \> 3 (more than 3 previous deliveries \> 22 weeks)
* History of cone biopsy and strapping
* Known fetal malformation
* Known allergy to prostaglandins
* Woman under guardianship
18 Years
50 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Tours
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jérôme POTIN
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Tours
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital of Nantes
Nantes, , France
Hospital of Orleans
Orléans, , France
University Hospital of Tours
Tours, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Arthuis C, Potin J, Winer N, Tavernier E, Paternotte J, Ramos A, Perrotin F, Diguisto C. Contribution of ultrasonography to the prediction of the induction-delivery interval: The ECOLDIA prospective multicenter cohort study. J Gynecol Obstet Hum Reprod. 2021 Dec;50(10):102196. doi: 10.1016/j.jogoh.2021.102196. Epub 2021 Jul 10.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PHRI09-JP/ECOLDIA
Identifier Type: -
Identifier Source: org_study_id